Abstract
Background
To investigate a possible structural difference in the retina of hydroxychloroquine (Plaquenil)-treated patients as an explanation for the protective effect of this medication against age-related macular degeneration (AMD).
Methods
In this retrospective study, we compared the mean thickness of the retinal outer band (consisting of the Bruch’s membrane and retinal pigment epithelium layer), as measured by optical coherence tomography (OCT), of 54 eyes of 27 hydroxychloroquine-treated rheumatoid arthritis patients (study group), 40 eyes of 20 healthy similar aged individuals (control group I), and 22 eyes of 11 non-hydroxychloroquine-treated rheumatoid arthritis patients (control group II).
Results
The mean thicknesses of the outer band of the retinal pigment epithelium layer was 60.4 ± 7.4, 43.3 ± 2.7, and 39.7 ± 3.6 μm for the study group, control group I, and control group II, respectively. P values for differences in mean thicknesses were < 0.0001 between the study group and each of the control groups, and 0.086 between the two control groups.
Conclusion
Treatment with hydroxychloroquine was associated with increased thickness of the outer band of the retinal pigment epithelium layer. This finding may explain the protective effect of hydroxychloroquine against age-related macular degeneration (AMD).
Similar content being viewed by others
References
Friedman DS, O’Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J, Eye Diseases Prevalence Research Group (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564–572
Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411–431
In’t Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Dutjn CM, StijnenT BMM, Stricker BH (2001) Non-steroidal anti inflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 345:1515–1521
McGeer PL, Schulzer M, McGeer EG, Sibley J (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease; a review of 17 epidemiological studies. Neurology 47:425–432
McGeer PL, Sibley J (2005) Sparing of age-related macular degeneration in rheumatoid arthritis. Neurobiol Aging J 26:1199–1203
Cox NH, Paterson WD (1994) Ocular toxicity of antimalarials in dermatology: a survey of current practice. Br J Dermatol 131:878–882
Coyle JT (2001) Hydroxychloroquine retinopathy. Ophthalmology 108:243–244
Bernstein HN, Ginsberg J (1964) The pathology of chloroquine retinopathy. Arch Ophthalmol 71:238–245
Cambiaggi A (1957) Unusual ocular lesions in a case of systemic lupus erythematosus. Arch Ophthalmol 57:451–453
Hobbs HE, Sorsby A, Freedman A (1959) Retinopathy following chloroquine therapy. Lancet 2:478–480
Korah S, Kuriakose T (2008) Optical coherence tomography in a patient with chloroquine-induced maculopathy. Indian J Ophthalmol 56:511–513
Rodriguez-Padilla JA, Hedges TR, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG (2007) High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 125:775–780
Ramsey MS, Fine BS (1972) Chloroquine toxicity in the human eye. Histopathologic observations by electron microscopy. Am J Ophthalmol 73:229–235
Author information
Authors and Affiliations
Corresponding author
Additional information
None of the authors has a financial relationship with manufacturers of Plaquenil.
All funding for the conduct of this study came from the departments of the investigators.
Rights and permissions
About this article
Cite this article
Pikkel, J., Chassid, O., Sharabi-Nov, A. et al. A retrospective evaluation of the effect of hydroxyquinine on RPE thickness. Graefes Arch Clin Exp Ophthalmol 251, 1687–1690 (2013). https://doi.org/10.1007/s00417-012-2256-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2256-5